Enhanced antitumor efficacy of nanostructured lipid carrier co-loaded with docetaxel and 5-fluorouracil for targeted gastric cancer therapy

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.

Article  PubMed  Google Scholar 

Ajani JA, D’Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, et al. Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20(2):167–92. https://doi.org/10.6004/jnccn.2022.0008.

Article  PubMed  Google Scholar 

Cai J, Qian K, Zuo X, Yue W, Bian Y, Yang J, et al. PLGA nanoparticle-based docetaxel/LY294002 drug delivery system enhances antitumor activities against gastric cancer. J Biomater Appl. 2019;33(10):1394–406. https://doi.org/10.1177/0885328219837683.

Article  PubMed  Google Scholar 

Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021;149(4):778–89. https://doi.org/10.1002/ijc.33588.

Article  Google Scholar 

Li Y, Wang Z, Gao P, Cao D, Dong R, Zhu M, et al. CircRHBDD1 promotes immune escape via IGF2BP2/PD-L1 signaling and acts as a nanotherapeutic target in gastric cancer. J Transl Med. 2024;22(1):704. https://doi.org/10.1186/s12967-024-05498-9.

Article  PubMed  PubMed Central  Google Scholar 

Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018. https://doi.org/10.2147/CMAR.S149619.

Article  PubMed  PubMed Central  Google Scholar 

Afrin H, Esquivel SV, Kumar R, Zahid MI, Oporeza B, Rahman MF, et al. β-glucan-mediated oral codelivery of 5FU and Bcl2 siRNA attenuates stomach cancer. ACS Appl Mater Interfaces. 2023;15(27):32188–200. https://doi.org/10.1021/acsami.3c03528.

Article  PubMed  PubMed Central  Google Scholar 

Huang H-L, Chen K-W, Liao H-W, Wang L-Y, Peng S-L, Lai C-H, et al. Nanoparticles for augmenting therapeutic potential and alleviating the effect of Di (2-ethylhexyl) phthalate on gastric cancer. ACS Appl Mater Interfaces. 2024;16(15):18285–99. https://doi.org/10.1021/acsami.3c15976.

Article  PubMed  PubMed Central  Google Scholar 

Gu E, Song W, Liu A, Wang H. SCDb: an integrated database of stomach cancer. BMC Cancer. 2020;20:1–10. https://doi.org/10.1186/s12885-020-06869-3.

Article  Google Scholar 

Hotchkiss KA, Ashton AW, Mahmood R, Russell RG, Sparano JA, Schwartz EL. Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center. Mol Cancer Ther. 2002;1(13):1191–200.

PubMed  Google Scholar 

Zhang E, Xing R, Liu S, Li K, Qin Y, Yu H, et al. Vascular targeted chitosan-derived nanoparticles as docetaxel carriers for gastric cancer therapy. Int J Biol Macromol. 2019;126:662–72. https://doi.org/10.1016/j.ijbiomac.2018.12.262.

Article  PubMed  Google Scholar 

Zheng D, Li D, Lu X, Feng Z. Enhanced antitumor efficiency of docetaxel-loaded nanoparticles in a human ovarian xenograft model with lower systemic toxicities by intratumoral delivery. Oncol Rep. 2010;23(3):717–24. https://doi.org/10.3892/or_00000689.

Article  PubMed  Google Scholar 

Engels FK, Mathot RA, Verweij J. Alternative drug formulations of docetaxel: a review. Anticancer Drugs. 2007;18(2):95–103. https://doi.org/10.1097/CAD.0b013e3280113338.

Article  PubMed  Google Scholar 

Alavi SE, Alharthi S, Alavi SZ, Raza A, Shahmabadi HE. Bioresponsive drug delivery systems. Drug Discov Today. 2024;29(1):103849. https://doi.org/10.1016/j.drudis.2023.103849.

Article  PubMed  Google Scholar 

Alavi SE, Alharthi S, Alavi SF, Alavi SZ, Zahra GE, Raza A, et al. Microfluidics for personalized drug delivery. Drug Discov Today. 2024;29(4):103936. https://doi.org/10.1016/j.drudis.2024.103936.

Article  PubMed  Google Scholar 

Alavi SE, Cabot PJ, Yap GY, Moyle PM. Optimized methods for the production and bioconjugation of site-specific, alkyne-modified glucagon-like peptide-1 (GLP-1) analogs to azide-modified delivery platforms using copper-catalyzed alkyne–azide cycloaddition. Bioconjug Chem. 2020;31(7):1820–34. https://doi.org/10.1021/acs.bioconjchem.0c00291.

Article  PubMed  Google Scholar 

Alavi SE, Cabot PJ, Moyle PM. Glucagon-like peptide-1 receptor agonists and strategies to improve their efficiency. Mol Pharm. 2019;16(6):2278–95. https://doi.org/10.1021/acs.molpharmaceut.9b00308.

Article  PubMed  Google Scholar 

Alavi SE, Shahmabadi HE. GLP-1 peptide analogs for targeting pancreatic beta cells. Drug Discov Today. 2021;26(8):1936–43. https://doi.org/10.1016/j.drudis.2021.03.032.

Article  PubMed  Google Scholar 

Alavi SE, Panah N, Page F, Gholami M, Dastfal A, Sharma LA, et al. Hydrogel-based therapeutic coatings for dental implants. Eur Polym J. 2022;181:111652. https://doi.org/10.1016/j.eurpolymj.2022.111652.

Article  Google Scholar 

Shahmabadi HE, Doun SKB, Alavi SE, Mortazavi M, Saffari Z, Farahnak M, et al. An investigation into the parameters affecting preparation of polybutyl cyanoacrylate nanoparticles by emulsion polymerization. Indian J Clin Biochem. 2014;29(3):357–61. https://doi.org/10.1007/s12291-013-0325-0.

Article  Google Scholar 

Alavi SE, Cabot PJ, Raza A, Moyle PM. Developing GLP-1 conjugated self-assembling nanofibers using copper-catalyzed alkyne–azide cycloaddition and evaluation of their biological activity. Bioconjug Chem. 2021;32(4):810–20. https://doi.org/10.1021/acs.bioconjchem.1c00091.

Article  PubMed  Google Scholar 

Yaghoubi F, Motlagh NSH, Naghib SM, Haghiralsadat F, Jaliani HZ, Moradi A. A functionalized graphene oxide with improved cytocompatibility for stimuli-responsive co-delivery of curcumin and doxorubicin in cancer treatment. Sci Rep. 2022;12(1):1959. https://doi.org/10.1038/s41598-022-05793-9.

Article  PubMed  PubMed Central  Google Scholar 

Alavi SE, Alavi SF, Koohi M, Raza A, Ebrahimi H, Shahmabadi. Nanoparticle-integrated metal–organic frameworks: a revolution in next-generation drug delivery systems. J Pharm Investig. 2024. https://doi.org/10.1007/s40005-024-00691-w.

Article  Google Scholar 

Li H, Wang S, Yang Z, Meng X, Niu M. Nanomaterials modulate tumor-associated macrophages for the treatment of digestive system tumors. Bioact Mater. 2024;36:376–412. https://doi.org/10.1016/j.bioactmat.2024.03.003.

Article  PubMed  PubMed Central  Google Scholar 

He C, Chan C, Weichselbaum RR, Fleming GF, Yamada SD, Lin W. Nanomedicine for combination therapy of cancer. EBioMedicine. 2015;2(5):366–7. https://doi.org/10.1016/j.ebiom.2015.05.013.

Article  PubMed  PubMed Central  Google Scholar 

Miao L, Daozhou L, Ying C, Qibing M, Siyuan Z. A resveratrol-loaded nanostructured lipid carrier hydrogel to enhance the anti-UV irradiation and anti-oxidant efficacy. Colloids Surf B Biointerfaces. 2021;204:111786. https://doi.org/10.1016/j.colsurfb.2021.111786.

Article  PubMed  Google Scholar 

Lakhani P, Patil A, Wu K-W, Sweeney C, Tripathi S, Avula B, et al. Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery. Int J Pharm. 2019;572:118771. https://doi.org/10.1016/j.ijpharm.2019.118771.

Article  PubMed  PubMed Central  Google Scholar 

Sadaquat H, Akhtar M, Nazir M, Ahmad R, Alvi Z, Akhtar N. Biodegradable and biocompatible polymeric nanoparticles for enhanced solubility and safe oral delivery of docetaxel: In vivo toxicity evaluation. Int J Pharm. 2021;598:120363. https://doi.org/10.1016/j.ijpharm.2021.120363.

Article  PubMed  Google Scholar 

Yusefi M, Lee-Kiun MS, Shameli K, Teow S-Y, Ali RR, Siew K-K, et al. 5-Fluorouracil loaded magnetic cellulose bionanocomposites for potential colorectal cancer treatment. Carbohydr Polym. 2021;273:118523. https://doi.org/10.1016/j.carbpol.2021.118523.

Article  PubMed  Google Scholar 

Park YI, Kwon S-H, Lee G, Motoyama K, Kim MW, Lin M, et al. pH-sensitive multi-drug liposomes targeting folate receptor β for efficient treatment of non-small cell lung cancer. J Control Release. 2021;330:1–14. https://doi.org/10.1016/j.jconrel.2020.12.011.

Article  PubMed  Google Scholar 

Alavi SE, Raza A, Esfahani MKM, Akbarzadeh A, Abdollahi SH, Shahmabadi HE. Carboplatin niosomal nanoplatform for potentiated chemotherapy. J Pharm Sci. 2022;111(11):3029–37. https://doi.org/10.1016/j.xphs.2022.06.002.

Article 

留言 (0)

沒有登入
gif